Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature

Langerhans cell histiocytosis (LCH) is a diagnostic and therapeutic challenge. We report on a rare case of its primary oral manifestation that was treated successfully with the BRAF-specific agent, vemurafenib, after insufficient standard LCH treatment. This case underlines the importance of proper...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Med Oncol
Main Authors: Neckel, Norbert, Lissat, Andrej, von Stackelberg, Arendt, Thieme, Nadine, Doueiri, Mohemed-Salim, Spors, Birgit, Beck-Broichsitter, Benedicta, Heiland, Max, Raguse, Jan-Dirk
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6801882/
https://ncbi.nlm.nih.gov/pubmed/31666812
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919878013
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados